HSKA - Heska CorporationAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $102.52 | Open | $102.99 |
| Volume | 25K | Market Cap | 563.86M |
| Yield | Last Dividend |
| Heska Corporation Reports Second Quarter... | 08/04/20 |
| LOVELAND, Colo., Aug. 4, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading provider of advanced veterinary diagno... | |
| Heska Corporation Second Quarter 2020 Fi... | 07/16/20 |
| LOVELAND, Colo., July 16, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading provider of advanced veterinary d... | |
| Global Veterinary PoC Diagnostics Market... | 06/02/20 |
| DUBLIN--(BUSINESS WIRE)--The "Veterinary PoC Diagnostics Market by Product (Imaging Systems, Analyzers, Reagents), Technology (Immuno & Molecular Diag... | |
| Heska (HSKA) Reports Q1 Loss, Misses Rev... | 05/07/20 |
| Heska (HSKA) delivered earnings and revenue surprises of 44.00% and -8.40%, respectively, for the quarter ended March 2020. Do the numbers hold clues ... | |
| Heska Corporation Reports First Quarter ... | 05/07/20 |
| LOVELAND, Colo., May 7, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading provider of advanced veterinary diagnos... | |
| Heska Corporation Expands Executive Lead... | 04/22/20 |
| LOVELAND, Colo., April 22, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a provider of advanced veterinary diagnost... | |
| Heska Corporation First Quarter 2020 Fin... | 04/16/20 |
| LOVELAND, Colo., April 16, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a provider of advanced veterinary diagnost... | |
| Covetrus Completes Sale of scil animal c... | 04/01/20 |
| PORTLAND, Maine--(BUSINESS WIRE)--Covetrus announced that it has completed the sale of its scil animal care business to Heska Corporation. | |
| Heska (HSKA) Surpasses Q4 Earnings Estim... | 02/25/20 |
| Heska (HSKA) delivered earnings and revenue surprises of 133.33% and -1.51%, respectively, for the quarter ended December 2019. Do the numbers hold cl... | |
| Heska Corporation Reports Fourth Quarter... | 02/25/20 |
| LOVELAND, Colo., Feb. 25, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA) ("Heska" or "Company"), a provider of advanced veterinary diagnostic a... | |
| Heska Corporation to Present at the Raym... | 02/18/20 |
| LOVELAND, Colo., Feb. 18, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary di... | |
| Global Animal Health Diagnostics Market ... | 01/30/20 |
| LONDON--(BUSINESS WIRE)-- #Healthcare--The global animal health diagnostics market is poised to grow by USD 1.69 billion during 2020-2024, progressing... | |
| Heska Corporation to Acquire scil animal... | 01/14/20 |
| LOVELAND, Colo., Jan. 14, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary di... | |
| Heska Corporation Announces Acquisition ... | 01/09/20 |
| LOVELAND, Colo., Jan. 9, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary dia... | |
| Heska Corporation to Present at the 38th... | 12/20/19 |
| LOVELAND, Colo., Dec. 20, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary di... | |
| Heska Corporation to Present at Upcoming... | 11/14/19 |
| LOVELAND, Colo., Nov. 14, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary di... | |
| Heska (HSKA) Reports Q3 Loss, Tops Reven... | 11/05/19 |
| Heska (HSKA) delivered earnings and revenue surprises of 25.00% and 2.61%, respectively, for the quarter ended September 2019. Do the numbers hold clu... | |
| Heska Corporation Reports Third Quarter ... | 11/05/19 |
| LOVELAND, Colo., Nov. 5, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary dia... | |
| Analysts Estimate Heska (HSKA) to Report... | 10/29/19 |
| Heska (HSKA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the... | |
| Heska Corporation (HSKA) CEO Kevin Wilso... | 05/10/19 |
| No summary available. | |
| Heska Corporation (HSKA) Q1 2019 Earning... | 05/07/19 |
| HSKA earnings call for the period ending March 31, 2019. | |
| Heska beats by $0.27, beats on revenue | 05/07/19 |
| No summary available. | |
| New finance chief at Heska | 05/06/19 |
| No summary available. | |
| BofA/ML cuts view on Karyopharm in prema... | 02/27/19 |
| No summary available. | |
| Heska's (HSKA) CEO Kevin Wilson on Q4 20... | 02/26/19 |
| No summary available. | |
| Heska down 2% on Q4 results | 02/26/19 |
| No summary available. | |
| Heska misses by $0.30, misses on revenue | 02/26/19 |
| No summary available. | |
| Date | 2020-08-04 (BMO) | Est. (EPS/Rev.) | ($0.34)/ 39.89M |
| Actual (EPS/Rev.) | / $45.71 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
